ClinicaliQ Trial Snapshot
- Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study) — Recruiting • Cardiology / Cardiovascular • NCT06695325.
- What is being tested: The Charm-D study evaluates home-based HbA1c testing as an alternative to traditional clinic-based blood tests for routine diabetes monitoring and glycaemic control assessment.
- Patient eligibility overview: The trial includes patients with diabetes mellitus requiring regular HbA1c monitoring to assess blood sugar control and reduce complication risk, with home access providing convenient routine measurement.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Diabetes mellitus is a global problem and regular monitoring of blood sugar control is important to reduce the risk of complications secondary to poor sugar control. To assess control a simple blood test is undertaken called the HbA1c. This test gives an assessment of the person's sugar control over the previous 3 months and needs to be done regularly so that changes can be made to their treatment. The HbA1c test is routinely performed in clinic and blood taken from a vein in the arm using a needle and syringe.…
Eligibility Snapshot
- : * Adult subjects aged 18 years and over at the time of signing the informed consent * Ability to provide Informed consent * Type I and II diabetic patient * Ability to understand written and spoken English * Ability to perform a blood draw at home
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.